These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23471840)

  • 1. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
    Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU
    Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
    Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
    BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
    Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
    Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a.
    Del Follo-Martinez A; Banerjee N; Li X; Safe S; Mertens-Talcott S
    Nutr Cancer; 2013; 65(3):494-504. PubMed ID: 23530649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
    Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
    Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
    BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
    Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
    Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
    Sreevalsan S; Safe S
    Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
    Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
    Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
    Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
    Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
    Li X; Pathi SS; Safe S
    BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
    Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
    Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
    Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
    Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S
    Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
    Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S
    Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.
    Nair V; Pathi S; Jutooru I; Sreevalsan S; Basha R; Abdelrahim M; Samudio I; Safe S
    Carcinogenesis; 2013 Dec; 34(12):2870-9. PubMed ID: 23803693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells].
    Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
    Li X; Zhao H; Zhou X; Song L
    Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.